ELAN
NYSEElanco Animal Health Incorporated
Price$23.56-0.43 (-1.79%)
01:30 PM07:45 PM
News · 26 weeks87-27%
2026-04-192026-10-11
Mix3590d
- Insider23(66%)
- Other7(20%)
- Earnings2(6%)
- SEC Filings2(6%)
- Analyst1(3%)
Latest news
25 items- ANALYSTGoldman initiated coverage on Elanco Animal Health with a new price targetGoldman initiated coverage of Elanco Animal Health with a rating of Buy and set a new price target of $32.00
- INSIDERSEC Form 4 filed by Elanco Animal Health Incorporated4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by Elanco Animal Health Incorporated4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by Elanco Animal Health Incorporated4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by Director Anand Kapila K4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by PRESIDENT, CEO AND DIRECTOR Simmons Jeffrey N4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by Officer Modi Rajeev A.4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by EVP and CFO Vanhimbergen Robert M4 - Elanco Animal Health Inc (0001739104) (Issuer)
- PRElanco to Participate in BofA Securities Global Healthcare Conference 2026INDIANAPOLIS, Sept. 17, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) will attend the BofA Securities Global Healthcare Conference 2026 on September 22, 2026. Jeff Simmons, president and CEO, will participate in a fireside chat on Tuesday, September 22 at 2:10 p.m. BST (9:10 a.m. EDT). A live audio webcast will be available in the "Events and Presentations" section of Elanco's investor website. A replay will be available for a limited time at the conclusion of the event.ABOUT ELANCOElanco Animal Health Incorporated (NYSE:ELAN) is a global leader in animal health dedicated to innovating and delivering produc
- PRExpanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness CareInnovation that protects against these pests is driving stronger Elanco base business and overall share gains.Elanco confirms U.S. Pet Health is on track to expectations of high-single digit to low double-digit growth in the second half of 2026.U.S. Pet Health price gains have accelerated quarter-to-date vs. Q2.INDIANAPOLIS, Sept. 15, 2026 /PRNewswire/ -- As the calendar turns to fall, Americans expect a seasonal reprieve from ticks and allergies. However, with warming temperatures and expanded pollen seasons we see the parasiticide and dermatology categories shifting toward year-round needs in these billion-dollar plus pet health markets.
- PRElanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results AnnouncementINDIANAPOLIS, Sept. 11, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) will announce its third quarter 2026 financial results on Friday, November 6, 2026. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance. The conference call will begin at 8:00 a.m. eastern time. Investors, media, and the general public can access a live webcast of the conference call through the link that will be posted on Elanco's website at https://investor.elanco.com/news-events/events-presentation. A replay will also be available on the website shor
- PRElanco to Participate in Morgan Stanley 24th Annual Global Healthcare ConferenceINDIANAPOLIS, Sept. 10, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) will attend the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026. Jeff Simmons, president and CEO, Bob VanHimbergen, executive vice president and CFO, and Bobby Modi, executive vice president U.S. Pet Health and Global Digital Transformation will participate in a fireside chat on Tuesday, September 15 at 2:35 p.m. ET. A live audio webcast will be available in the "Events and Presentations" section of Elanco's investor website. A replay will be available for a limited time at the conclusion of the event.ABOUT E
- INSIDERSEC Form 4 filed by EVP and CFO Vanhimbergen Robert M4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by Officer Modi Rajeev A.4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by PRESIDENT, CEO AND DIRECTOR Simmons Jeffrey N4 - Elanco Animal Health Inc (0001739104) (Issuer)
- PRElanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing FacilityThe completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipelineINDIANAPOLIS, Aug. 26, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) today announced the on-time completion of a 25,000-square-foot manufacturing expansion of its Elwood, Kansas manufacturing site. As one of only two animal health companies with mAb solutions on the market today, the expansion further strengthens Elanco's leadership in the biologics space. "When we announced the expansion two years ago, we recognized that executing the most exciting pipe
- INSIDERSEC Form 4 filed by Officer Modi Rajeev A.4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by EVP and CFO Vanhimbergen Robert M4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by PRESIDENT, CEO AND DIRECTOR Simmons Jeffrey N4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERDirector Kurzius Lawrence Erik bought $935,920 worth of shares (40,000 units at $23.40), increasing direct ownership by 27% to 188,647 units (SEC Form 4)4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERGC AND CORP SEC O'Neill Shiv bought $94,273 worth of shares (3,998 units at $23.58), increasing direct ownership by 5% to 87,832 units (SEC Form 4)4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERDirector Harrington Michael J bought $109,100 worth of shares (5,000 units at $21.82), increasing direct ownership by 4% to 131,451 units (SEC Form 4)4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by PRESIDENT, CEO AND DIRECTOR Simmons Jeffrey N4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDEREVP and CFO Vanhimbergen Robert M bought $96,926 worth of shares (4,200 units at $23.08), increasing direct ownership by 3% to 137,516 units (SEC Form 4)4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by Officer Modi Rajeev A.4 - Elanco Animal Health Inc (0001739104) (Issuer)
ELAN FAQ
7 questionsWhat does Elanco Animal Health Incorporated do?
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and...Where does ELAN stock trade?
Elanco Animal Health Incorporated (ELAN) is listed on NYSE.What sector and industry is ELAN in?
Elanco Animal Health Incorporated operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Elanco Animal Health Incorporated go public?
Elanco Animal Health Incorporated (ELAN) completed its IPO in 2018.What are analysts saying about ELAN?
Elanco Animal Health Incorporated has had 8 recent analyst actions on file. The most recent action was from Goldman: Buy with a $3200.00 price target on 2026-10-16. Recent price targets range from $1800.00 to $3200.00.What companies are similar to ELAN?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare ELAN side-by-side with any of them on Quantisnow.How can I track ELAN on Quantisnow?
Quantisnow aggregates Elanco Animal Health Incorporated's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ELAN to receive live email and push alerts on every new disclosure.